Continuous infusion interleukin-2 and tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study Group Trial.
- R. K. Oldham
- , R. O. Dillman
- , J. R. Yannelli
- , N. M. Barth
- , J. R. Maleckar
- , A. Sferruzza
- , R. J. Cohen
- , D. R. Minor
- , L. Spitler
- , R. Birch
Producción científica: Article › revisión exhaustiva
24
Citas
(Scopus)